| Novartis Pharma Schweiz AG - Certican 0.1 mg, dispergierbare Tabletten | | 56239 | | 02 | | Certican 0.1 mg | | dispergierbare Tabletten | | L04AA18 | | Everolimus | | 21.04.2005 | | |
| | Composition | | everolimusum 0.1 mg, lactosum monohydricum 0.89 mg, hypromellosum, magnesii stearas, silica colloidalis anhydrica, crospovidonum, lactosum 71.5 mg, E 321, pro compresso. | | Packungsbestandteile | | Dispersible Tablets | | | | | Active Agent | Dose |
|---|
| Everolimus | 0.1 mg |
| | BAG: Active Agent | Dose |
|---|
| Everolimus | 0.1 mg |
| | | | Inactive agents | Dose |
|---|
| Crospovidonum | | | E 321 | | | Hypromellosum | | | Lactosum | 71.5 mg | | Lactose Monohydrate | 0.89 mg | | Magnesii Stearas | | | Pro Compresso | | | Silica Colloidalis Anhydrica | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 60 Tablet(s) | 58.26 | 79.80 | B | SL | No |
|
|
